OxThera AB
556681-5667ActiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2005
- Founded
Key Decision Makers
Jonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Description
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556681566701
Decision Makers
4 contacts in FunnelfeedrJonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Similar Companies
20 similar companies in FunnelfeedrULTRAGENYX EUROPE GMBH
1–4 employeesAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
BioGaia Pharma AB
0 employeesDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Sixera Pharma AB
1–4 employeesSmall biotech developing first treatment for rare Netherton syndrome.
Calliditas Therapeutics AB
20–49 employeesPioneering novel treatments for rare renal and hepatic diseases globally.
BridgeBio International GmbH
1–4 employeesDeveloping transformative medicines for rare genetic conditions quickly.
Browse More
OxThera AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo